INCY vs MMSI: fair value comparison
Incyte Corporation and Merit Medical Systems, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, MMSI currently sits closer to the top of our discount ranking.
| INCY | MMSI | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $124.37 | $85.53 |
| 12-month range | $85.98–$119.52 | $62.01–$90.68 |
| Sector rank | #35 of 113 Healthcare | #33 of 113 Healthcare |
| Quality grade | A | A |
| Momentum grade | A | A |
| Leverage | Low | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Uptrend |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: INCY fair value analysis · MMSI fair value analysis